OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.
OccamzRazor has raised $6.1M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
OccamzRazor's investors include Valor Equity Partners, Human Capital, Michael J. Fox Foundation, Positive Ventures, Jeff Dean.
OccamzRazor is headquartered in New York, United States.
OccamzRazor is a combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development.
OccamzRazor is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OccamzRazor — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/occamzrazor. Accessed September 29, 2026.
VCBacked. (2022). OccamzRazor — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/occamzrazor
{{cite web |title=OccamzRazor — Funding & Investors |url=https://www.vcbacked.co/company/occamzrazor |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated